drugset / Trial / NCT07276867

Intrathecal Dexmedetomidine-Fentanyl Combination Versus Fentanyl Alone as Adjuvant to Bupivacaine in Spinal Anesthesia for Above Knee Amputation in Sarcomas of Lower Extremity

NCT07276867 ↗

Recruiting 58 enrolled National Cancer Institute, Egypt
RandomizedParallel-groupDouble-blindTreatment

Summary

The current work evaluated whether the combination of intrathecal dexmedetomidine and fentanyl provides superior postoperative analgesia to fentanyl alone when administered with hyperbaric bupivacaine.

Timeline

Start
2025-10-20
Primary completion
2026-04-01
Completion
2026-04-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 5 ug Intrathecal
Comparator Fentanyl Other / unclassified 25 ug Intrathecal

Indications